AU2195395A - Synthetic peptide based immunogens for the treatment of allergy - Google Patents

Synthetic peptide based immunogens for the treatment of allergy

Info

Publication number
AU2195395A
AU2195395A AU21953/95A AU2195395A AU2195395A AU 2195395 A AU2195395 A AU 2195395A AU 21953/95 A AU21953/95 A AU 21953/95A AU 2195395 A AU2195395 A AU 2195395A AU 2195395 A AU2195395 A AU 2195395A
Authority
AU
Australia
Prior art keywords
gly
lys
phe
val
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21953/95A
Other languages
English (en)
Inventor
Chang Yi Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Biomedical Inc
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of AU2195395A publication Critical patent/AU2195395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU21953/95A 1994-03-28 1995-03-24 Synthetic peptide based immunogens for the treatment of allergy Abandoned AU2195395A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21846194A 1994-03-28 1994-03-28
US218461 1994-03-28
US32891294A 1994-10-25 1994-10-25
US328912 1994-10-25
PCT/US1995/003741 WO1995026365A1 (en) 1994-03-28 1995-03-24 Synthetic peptide based immunogens for the treatment of allergy

Publications (1)

Publication Number Publication Date
AU2195395A true AU2195395A (en) 1995-10-17

Family

ID=26912926

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21953/95A Abandoned AU2195395A (en) 1994-03-28 1995-03-24 Synthetic peptide based immunogens for the treatment of allergy

Country Status (6)

Country Link
EP (1) EP0811016A1 (enrdf_load_stackoverflow)
JP (1) JPH09510975A (enrdf_load_stackoverflow)
CN (1) CN1146772A (enrdf_load_stackoverflow)
AU (1) AU2195395A (enrdf_load_stackoverflow)
CA (1) CA2186595A1 (enrdf_load_stackoverflow)
WO (1) WO1995026365A1 (enrdf_load_stackoverflow)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843462A (en) * 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
CN1174998C (zh) * 1996-03-01 2004-11-10 诺瓦提斯公司 用于预防和治疗过敏的肽免疫原
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
WO1999030736A2 (en) 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EA200101125A1 (ru) 1999-04-23 2002-04-25 Фармекса А/С Способ понижающей регуляции активности il5
GB9913327D0 (en) * 1999-06-08 1999-08-11 Smithkline Beecham Biolog Vaccine
US6846486B1 (en) 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
AU2001245835A1 (en) * 2000-03-15 2001-09-24 Heska Corporation Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof
AU7658101A (en) * 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
AU2001285721A1 (en) * 2000-09-06 2002-03-22 Pharmexa A/S Method for down-regulating IgE
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP2003047482A (ja) 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
AU2002326751A1 (en) 2001-08-13 2003-03-03 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
US8697846B2 (en) * 2007-08-15 2014-04-15 Emory University Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology
CA2717930A1 (en) * 2008-03-13 2009-09-17 Yossef Kliger Novel gp96 derived peptides
EP2788021B1 (en) 2011-12-09 2017-01-18 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
US9187553B2 (en) * 2012-01-25 2015-11-17 Swey-Shen Chen Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
WO2013191166A1 (ja) * 2012-06-18 2013-12-27 日本全薬工業株式会社 IgEペプチドワクチン
EP2790442A1 (en) 2013-04-09 2014-10-15 Alcatel Lucent Control system, apparatus, methods, and computer readable storage medium storing instructions for a network node and/or a network controller
CN112237638B (zh) * 2020-10-28 2022-11-29 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5552537A (en) * 1993-03-24 1996-09-03 The Regents Of The University Of California IgE isoforms and methods of use
ES2180576T3 (es) * 1993-04-27 2003-02-16 United Biomedical Inc Construcciones peptidicas de lhrh inmunogenicas y estimuladores de inmunidad universales sinteticos para vacunas.
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds

Also Published As

Publication number Publication date
JPH09510975A (ja) 1997-11-04
EP0811016A1 (en) 1997-12-10
CA2186595A1 (en) 1995-10-05
CN1146772A (zh) 1997-04-02
WO1995026365A1 (en) 1995-10-05
EP0811016A4 (enrdf_load_stackoverflow) 1997-12-10

Similar Documents

Publication Publication Date Title
AU2195395A (en) Synthetic peptide based immunogens for the treatment of allergy
EP1090039B1 (en) Peptide composition as immunogen for the treatment of allergy
CA2329772C (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
US5759551A (en) Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
EP0708656B1 (en) Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
WO1994025060A9 (en) Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
EP1087787A1 (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
AU4012095A (en) Synthetic ige membrane anchor peptide immunogens for the treatment of allergy
WO2002051860A2 (en) Synthetic peptide composition as immunogens for prevention of urinary tract infection
Wang B cell & T cell epitope orientation and adjuvant-free immunization in synthetic vaccine design
HK1036804B (en) Peptide composition as immunogen for the treatment of allergy
HK1143950B (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
HK1037860B (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
MXPA00011938A (en) Peptide composition as immunogen for the treatment of allergy
MXPA00011939A (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptideimmunogens